Parkside Financial Bank & Trust’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9K Hold
748
﹤0.01% 1400
2025
Q4
$12.2K Hold
748
﹤0.01% 1499
2025
Q3
$8.74K Sell
748
-32
-4% -$417 ﹤0.01% 1565
2025
Q2
$9.03K Buy
780
+557
+250% +$5.08K ﹤0.01% 1509
2025
Q1
$1.95K Buy
223
+45
+25% +$567 ﹤0.01% 1895
2024
Q4
$2.56K Sell
178
-183
-51% -$2.89K ﹤0.01% 1586
2024
Q3
$8.15K Sell
361
-68
-16% -$1.41K ﹤0.01% 1312
2024
Q2
$8.35K Buy
429
+269
+168% +$7.04K ﹤0.01% 1235
2024
Q1
$6.01K Hold
160
﹤0.01% 1295
2023
Q4
$8.96K Buy
160
+43
+37% +$1.87K ﹤0.01% 1169
2023
Q3
$4.83K Buy
117
+9
+8% +$468 ﹤0.01% 1386
2023
Q2
$6.03K Hold
108
﹤0.01% 1291
2023
Q1
$6.03K Hold
108
﹤0.01% 1290
2022
Q4
$3.94K Buy
108
+20
+23% +$654 ﹤0.01% 1417
2022
Q3
$3K Buy
88
+70
+389% +$2.67K ﹤0.01% 1462
2022
Q2
$1K Sell
18
-34
-65% -$1.76K ﹤0.01% 1771
2022
Q1
$4K Buy
52
+50
+2,500% +$4.37K ﹤0.01% 1424
2021
Q4
$0 Sell
2
-8
-80% -$1.23K ﹤0.01% 1921
2021
Q3
$1K Buy
10
+4
+67% +$687 ﹤0.01% 1714
2021
Q2
$1K Buy
6
+3
+100% +$543 ﹤0.01% 1674
2021
Q1
$1K Hold
3
﹤0.01% 1648
2020
Q4
$0 Buy
+3
New +$435 ﹤0.01% 1681

Other funds holding TXG

Parkside Financial Bank & Trust's TXG Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its 10x Genomics (TXG) position steady in Q1 2026 at 748 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Parkside Financial Bank & Trust first reported a position in TXG in Q4 2020 and has held it in 22 quarters since. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Parkside Financial Bank & Trust held 748 shares of 10x Genomics worth $15.9K as of Q1 2026.
  • Parkside Financial Bank & Trust left its 10x Genomics share count unchanged in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1400 holding.
  • Parkside Financial Bank & Trust first reported a position in 10x Genomics in Q4 2020 and has held it in 22 quarters since.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.